Boston Scientific Corp. BSX

NYS: BSX | ISIN: US1011371077   7/06/2023
50,70 USD (+0,06%)
(+0,06%)   7/06/2023

30 mei 2023 · Boston Scientific Announces Conversion Date of Series A Mandatory Convertible Preferred Stock · Persbericht

20 mei 2023 · Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies · Persbericht

15 mei 2023 · Boston Scientific to Participate in Bernstein's 39th Annual Strategic Decisions Conference · Persbericht

26 april 2023 · Boston Scientific Announces Results for First Quarter 2023 · Persbericht

3 april 2023 · Boston Scientific Announces Conference Call Discussing First Quarter 2023 Results · Persbericht

13 februari 2023 · Boston Scientific to Participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference · Persbericht

4 februari 2023 · BOSTON SCIENTIFIC INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX · Persbericht

3 februari 2023 · Boston Scientific Receives FDA Clearance for LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System · Persbericht

1 februari 2023 · Boston Scientific Announces Results For Fourth Quarter And Full Year 2022 · Persbericht

1 februari 2023 · Mee met de markt: 'Vergeet alles en wacht op de FED' · Bolero.be

We zouden de aandelenbeurzen op dagen zoals gisteren misschien beter eventjes sluiten, wat denkt u? Tot en met we weten wat de Amerikaanse centrale bank morgen zal zeggen over het toekomstige rentepad en de visie op langere...

3 januari 2023 · Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2022 Results · Persbericht

11 december 2022 · Boston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings Limited · Persbericht

29 november 2022 · Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc. · Persbericht

27 november 2022 · Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2™ Aortic Valve System · Persbericht

1 november 2022 · Boston Scientific Announces Upcoming Conference Schedule · Persbericht

26 oktober 2022 · Boston Scientific Announces Results for Third Quarter 2022 · Persbericht

3 oktober 2022 · Boston Scientific Announces Conference Call Discussing Third Quarter 2022 Results · Persbericht

17 september 2022 · Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL™ Cerebral Protection System · Persbericht

6 september 2022 · Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option · Persbericht

16 augustus 2022 · Boston Scientific Announces Upcoming Conference Schedule · Persbericht

Mijn selecties